Organo Corporation (TYO:6368)
Japan · Delayed Price · Currency is JPY 13,575
+150 (1.12%)
Aug 21, 2026, 3:30 PM JST
Organo Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 181,727 | 177,654 | 163,269 | 150,356 | 132,426 | 112,069 | |
Revenue Growth | 7.05% | 8.81% | 8.59% | 13.54% | 18.16% | 11.36% |
Cost of Revenue | 115,989 | 112,570 | 108,087 | 106,514 | 97,449 | 83,556 |
Gross Profit | 65,738 | 65,084 | 55,182 | 43,842 | 34,977 | 28,513 |
Selling, General & Admin | 28,430 | 27,435 | 20,746 | 21,297 | 17,104 | 15,469 |
Research & Development | - | - | 3,253 | - | 2,615 | 2,146 |
Operating Expenses | 28,430 | 27,435 | 24,061 | 21,297 | 19,763 | 17,662 |
Operating Income | 37,308 | 37,649 | 31,121 | 22,545 | 15,214 | 10,851 |
Interest Expense | -329 | -298 | -246 | -240 | -159 | -127 |
Interest & Investment Income | 309 | 282 | 151 | 186 | 79 | 59 |
Earnings From Equity Investments | 177 | 163 | 122 | 203 | 208 | 160 |
Currency Exchange Gain (Loss) | 896 | 271 | 383 | 546 | 559 | 573 |
Other Non Operating Income (Expenses) | 60 | 63 | 107 | 186 | 118 | 121 |
EBT Excluding Unusual Items | 38,421 | 38,130 | 31,638 | 23,426 | 16,019 | 11,637 |
Gain (Loss) on Sale of Investments | 150 | 150 | 724 | 191 | 39 | 23 |
Gain (Loss) on Sale of Assets | 4 | 44 | 4 | 70 | 5 | 1,148 |
Asset Writedown | -15 | -15 | -9 | -55 | -28 | -113 |
Other Unusual Items | - | - | - | - | -1 | - |
Pretax Income | 38,560 | 38,309 | 32,357 | 23,632 | 16,034 | 12,695 |
Income Tax Expense | 10,365 | 9,908 | 8,171 | 6,298 | 4,270 | 3,470 |
Earnings From Continuing Operations | 28,195 | 28,401 | 24,186 | 17,334 | 11,764 | 9,225 |
Minority Interest in Earnings | - | - | -36 | -24 | -34 | -15 |
Net Income | 28,195 | 28,401 | 24,150 | 17,310 | 11,730 | 9,210 |
Net Income to Common | 28,195 | 28,401 | 24,150 | 17,310 | 11,730 | 9,210 |
Net Income Growth | 12.26% | 17.60% | 39.52% | 47.57% | 27.36% | 30.20% |
Shares Outstanding (Basic) | 46 | 46 | 46 | 46 | 46 | 46 |
Shares Outstanding (Diluted) | 46 | 46 | 46 | 46 | 46 | 46 |
Shares Change | 0.01% | 0.02% | 0.09% | 0.14% | -0.07% | 0.03% |
EPS (Basic) | 613.20 | 617.74 | 525.37 | 376.92 | 255.76 | 200.67 |
EPS (Diluted) | 613.20 | 617.74 | 525.37 | 376.92 | 255.76 | 200.67 |
EPS Growth | 12.24% | 17.58% | 39.38% | 47.37% | 27.45% | 30.15% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | - | 18,838 | - | -19,741 | 8,295 |
Free Cash Flow Per Share | - | - | 409.81 | - | -430.43 | 180.74 |
Dividend Per Share | 200.000 | 200.000 | 160.000 | 102.000 | 62.000 | 40.000 |
Dividend Growth | 25.00% | 25.00% | 56.86% | 64.52% | 55.00% | 40.35% |
Gross Margin | 36.17% | 36.63% | 33.80% | 29.16% | 26.41% | 25.44% |
Operating Margin | 20.53% | 21.19% | 19.06% | 14.99% | 11.49% | 9.68% |
Profit Margin | 15.52% | 15.99% | 14.79% | 11.51% | 8.86% | 8.22% |
Free Cash Flow Margin | - | - | 11.54% | - | -14.91% | 7.40% |
EBITDA | 39,303 | 39,630 | 33,046 | 24,555 | 17,038 | 12,183 |
EBITDA Margin | 21.63% | 22.31% | 20.24% | 16.33% | 12.87% | 10.87% |
D&A For EBITDA | 1,995 | 1,981 | 1,925 | 2,010 | 1,824 | 1,332 |
EBIT | 37,308 | 37,649 | 31,121 | 22,545 | 15,214 | 10,851 |
EBIT Margin | 20.53% | 21.19% | 19.06% | 14.99% | 11.49% | 9.68% |
Effective Tax Rate | 26.88% | 25.86% | 25.25% | 26.65% | 26.63% | 27.33% |